scispace - formally typeset
Search or ask a question

How long do Covid antibodies from the vaccine last? 

Vaccination
Persistence (computer science)
Antibody
Hepatitis A
Hepatitis A vaccine

Answers from top 7 papers

More filters
Papers (7)Insight
Open access•Journal Article•DOI
Seventeen-year antibody persistence in adults primed with two doses of an inactivated hepatitis A vaccine
Koen Van Herck, Priya Diana Crasta, Marc Messier, Karin Hardt, Pierre Van Damme 
13 Feb 2012-Human Vaccines & Immunotherapeutics
32 Citations
Both HAV immunisation regimens (0,6 mo and 0,12 mo) induced persistence of vaccine-induced antibodies against HAV for at least 17 y after primary vaccination.
Journal Article•DOI
Antibody persistence and immune memory in adults, 15 years after a three‐dose schedule of a combined hepatitis A and B vaccine
P. Van Damme, Geert Leroux-Roels, P. Crasta, Marc Messier, Jeanne-Marie Jacquet, K. Van Herck 
01 Jan 2012-Journal of Medical Virology
21 Citations
This study confirms the long‐term immunogenicity of the three‐dose regimen of the combined hepatitis A and B vaccine, as eliciting long‐term persistence of antibodies and immune memory against hepatitis A and B for up to at least 15 years after a primary vaccination.
Open access•Journal Article•DOI
[Long-term immunogenicity and effectiveness of live attenuated hepatitis A vaccine (H2-strain)-a study on the result of 15 years' follow up].
Fang-cheng Zhuang, Zi-an Mao, L Jiang, Jie Wu, Yue-qing Chen, Qi Jiang, Nian-liang Chen, Chai Shao'ai, Jiang-sen Mao 
01 Dec 2010-Chinese journal of epidemiology
13 Citations
The long-term immunogenicity and effectiveness of live attenuated hepatitis A vaccine (H2 strain) after one dose injection could last as long as 15 years.
Journal Article•DOI
Long-term persistence of antibody following immunization with pneumococcal polysaccharide vaccine.
Maurice A. Mufson, Helen E. Krause, Gerald Schiffman 
01 Jun 1983-Experimental Biology and Medicine
67 Citations
These findings confirm the long-term persistence of vaccine-induced type-specific pneumococcal antibodies and suggest that the interval between repeated doses of pneumococcal vaccine should be at least 5 years.
Open access•Journal Article•DOI
Prolonged shedding of severe acute respiratory syndrome coronavirus 2 in patients with COVID-19.
Qian Li, Xiao Shuang Zheng, Xu Rui Shen, Hao Rui Si, Xi Wang, Qi Wang, Bei Li, Wei Zhang, Yan Zhu, Ren Di Jiang, Kai Zhao, Hui Wang, Zhengli Shi, Hui Lan Zhang, Rong Hui Du, Peng Zhou 
16 Nov 2020-Emerging microbes & infections
64 Citations
In summary, although patients with COVID-19 generated neutralizing antibodies, they may still shed infectious SARS-CoV-2 for over 3 months.
Journal Article•DOI
Long-term persistence of tick-borne encephalitis antibodies in adults 5 years after booster vaccination with Encepur Adults.
Annelie Plentz, Wolfgang Jilg, Tino F. Schwarz, Hans B. Kuhr, Olaf Zent 
05 Feb 2009-Vaccine
33 Citations
These results indicate that initially high levels of TBE antibodies following the first booster dose of the vaccine may lead to long-term persistence of TBE antibodies, confirming previous findings and suggesting it may be appropriate to extend the interval between booster doses from 3 to 5 years.
Open access•Journal Article•DOI
Persistence of serum and saliva antibody responses to SARS-CoV-2 spike antigens in COVID-19 patients.
Baweleta Isho, Kento T. Abe, Kento T. Abe, Michelle Zuo, Alainna J Jamal, Alainna J Jamal, Bhavisha Rathod, Jenny Wang, Zhijie Li, Gary Chao, Olga L. Rojas, Yeo Myong Bang, Annie Pu, Natasha Christie-Holmes, Christian Gervais, Derek F. Ceccarelli, Payman Samavarchi-Tehrani, Furkan Guvenc, Patrick Budylowski, Angel Li, Aimee Paterson, Feng Yun Yue, Lina María Marín, Lauren Caldwell, Jeffrey L. Wrana, Jeffrey L. Wrana, Karen Colwill, Frank Sicheri, Frank Sicheri, Samira Mubareka, Scott D. Gray-Owen, Steven J. Drews, Walter L. Siqueira, Miriam Barrios-Rodiles, Mario A. Ostrowski, Mario A. Ostrowski, James M. Rini, Yves Durocher, Allison McGeer, Allison McGeer, Allison McGeer, Jennifer L. Gommerman, Anne-Claude Gingras, Anne-Claude Gingras 
08 Oct 2020-Science immunology
583 Citations
This study confirms that serum and saliva IgG antibodies to SARS-CoV-2 are maintained in the majority of COVID-19 patients for at least 3 months PSO.

Related Questions

Can Covid antibodies last for years?8 answers
How long do I have antibodies after the Covid vaccine?5 answers
How long do antibodies last after Covid infections?3 answers
How long do antibodies last after a Covid vaccine?5 answers
How long do antibodies last from the Covid vaccine?7 answers
How long do you have Covid antibodies after vaccine?5 answers

See what other people are reading

Covid 19 and IgG and IgM antibodies protection from severe covid?
5 answers
Anti-SARS-CoV-2 IgG antibodies play a crucial role in protecting individuals from severe COVID-19. Studies have shown that higher levels of IgG antibodies are associated with protection against severe disease, indicating a stronger immune response. Additionally, the avidity of IgG antibodies against SARS-CoV-2 spike protein is linked to protection from symptomatic COVID-19, highlighting the importance of antibody quality in immunity. Furthermore, convalescent plasma containing IgG antibodies has demonstrated dose-dependent protection in animal models, emphasizing the significance of neutralizing IgG antibodies in preventing disease. Overall, the presence of IgG antibodies, their levels, and quality are essential factors in providing protection against severe COVID-19, showcasing the critical role of humoral immunity in combating the virus.What are the Mechanism of antibody transfer from mother to fetus?
5 answers
The mechanism of antibody transfer from mother to fetus involves intricate processes mediated by various receptors. FcRn plays a crucial role in passive immunity transfer, while FcγRIIb expressed in fetal endothelium contributes to subclass-specific IgG transfer. The selective transplacental IgG transfer is influenced by factors like Fc receptor binding affinity, IgG subclass abundance, and placental properties. Computational models have been developed to understand the determinants of antibody transfer, highlighting inter-subclass competition for receptor binding and the impact of maternal antibody repertoire and vaccination timing on transfer efficiency. These insights pave the way for personalized immunization strategies tailored to optimize prenatal transfer of protective antibodies and enhance neonatal immunity.What is the current status of respiratory viral infection in patients with chronic lung diseases?
5 answers
Respiratory viral infections play a significant role in patients with chronic lung diseases. Studies indicate that viruses, such as human rhinovirus, respiratory syncytial virus, and influenza, are commonly detected during exacerbations of chronic obstructive pulmonary disease (COPD). These infections can lead to acute exacerbations of COPD, resulting in increased morbidity and mortality. Furthermore, the ongoing COVID-19 pandemic has raised concerns about managing patients with COPD and the potential impact of SARS-CoV-2 infection on this population. The prevalence of respiratory viruses during acute exacerbations of COPD is higher compared to stable COPD patients, emphasizing the importance of understanding and managing viral infections in individuals with chronic lung diseases. Efforts to develop effective antiviral strategies for COPD patients are ongoing, highlighting the need for further research in this area.Which is the world health organzation minimal vaccination coverage to gain heard immunity?
4 answers
The World Health Organization (WHO) emphasizes the importance of achieving high vaccination coverage to establish herd immunity against vaccine-preventable diseases. WHO's Expanded Programme on Immunization (EPI) aims to provide protection through routine immunization, with global coverage for key vaccines like DTP3, MCV1, and Pol3 reaching around 84%-86%. To ensure effective immunization programs, it is crucial to reach and sustain high coverage levels, with DTP3 coverage being a key indicator of program performance. Additionally, WHO recognizes the need for equitable access to vaccines to increase protection against diseases, especially in underserved regions. By extending immunization coverage and improving access to vaccines, WHO strives to lighten the burden on health infrastructures and enhance overall development in developing communities.Does social media platforms have the capacity to fact check vaccination critics?
5 answers
Social media platforms possess the capability to fact-check vaccination critics. Studies highlight the prevalence of anti-vaccination content on platforms like Twitter, emphasizing the need to combat misinformation globally. Research underscores the effectiveness of leveraging network effects in detecting vaccination skeptic content, showcasing the importance of combining network and text embeddings for accurate classification. Furthermore, the identification of misinformation patterns and the development of machine learning models aid in automatically detecting and addressing vaccine misinformation on social media platforms. By collaborating with technological platforms, focusing on key misinformation areas, and addressing emotional triggers induced by personal beliefs, public health institutions can work towards mitigating the spread of health-related misinformation online.Does social media platforms are taking action to fact check vaccination critics?
5 answers
Social media platforms are indeed taking action to fact-check vaccination critics. Studies reveal that during the COVID-19 pandemic, Twitter's content moderation efforts, including user suspensions post the US Capitol attack, had a global impact in reducing the spread of vaccine-related misinformation. Additionally, the importance of addressing vaccine mis/disinformation on social media is emphasized, with suggestions to collaborate with tech platforms to tackle anonymous anti-vaccine content and focus on countering misinformation related to the medical nature of vaccines, manipulation beliefs, and freedom of health choice discourse. These findings underscore the significance of social media platforms in combating vaccine skepticism and promoting accurate health information.What are The Impact of Healthcare Accessibility on Maternal Knowledge Regarding Childhood Immunization in Urban Areas of Bangladesh?
5 answers
Healthcare accessibility significantly influences maternal knowledge regarding childhood immunization in urban areas of Bangladesh. Studies show that urban slum populations face challenges in accessing critical maternal and child health services due to migration status and socio-economic disparities. Additionally, inadequate accessibility to health services, financial difficulties, and discrepancies in service availability impact maternal knowledge on vaccination schedules. Efforts to improve health outcomes in urban areas, such as the Urban Primary Health Care Project, have shown positive results in enhancing maternal and child healthcare services and knowledge on immunization schedules. Encouraging mothers to retain and refer to their children's immunization cards can improve the accuracy of vaccination reporting, especially among educated and economically stable mothers. Addressing healthcare accessibility issues is crucial for enhancing maternal knowledge and ensuring effective childhood immunization in urban Bangladesh.What are the current trends in in silico research on alpacas?
5 answers
Current trends in in silico research on alpacas encompass diverse areas. Studies have focused on genomic breeding value prediction using methods like GBLUP and ssGBLUP to enhance genetic gains. Additionally, investigations into alpaca genetics have identified mutations in the ASIP gene associated with black fiber color, aiding selective breeding efforts. Furthermore, the application of artificial intelligence, specifically multiple linear regression with stochastic gradient descent, has been utilized to predict fiber quality in white Huacaya alpacas effectively. Moreover, the discovery of a novel BoV strain in alpacas through next-generation sequencing highlights the importance of ongoing research in virology and disease management in these animals. These trends collectively showcase the multidimensional approach of in silico research in advancing various aspects of alpaca studies.What is the role of antimicrobial peptides in the development and treatment of tuberculosis and the delivery?
8 answers
Antimicrobial peptides (AMPs) play a crucial role in the development and treatment of tuberculosis (TB) due to their unique mechanisms of action and potential to address drug-resistant strains of Mycobacterium tuberculosis (Mtb). AMPs, with their amphipathic cationic structures, exhibit a selective affinity for the negatively charged bacterial cell wall, enabling them to directly kill mycobacteria through membrane disruption or by interfering with cellular processes such as DNA, RNA, and protein synthesis. This direct bactericidal activity, coupled with their role in modulating the host's innate immune response, positions AMPs as promising candidates for developing novel anti-TB therapies. The global burden of TB, exacerbated by the emergence of drug-resistant TB strains, underscores the urgent need for new therapeutic agents. AMPs, both synthetic and natural, have shown potent anti-mycobacterial activity in vitro and in vivo, suggesting their potential as alternative or complementary agents in TB treatment regimens. Computational and experimental studies have further explored the efficacy of AMPs against Mtb, designing peptides with specific binding affinities to target proteins essential for bacterial survival. Moreover, AMPs offer a dual antimicrobial and anticancer function, which is particularly relevant given the correlation between TB and lung cancer. This multifunctionality could lead to combined therapies that address both TB and its associated conditions. Despite challenges related to bioavailability, cost, and large-scale production, ongoing research aims to overcome these hurdles, enhancing the therapeutic potential of AMPs against TB. Innovative delivery mechanisms, such as the use of adenoviruses to express AMPs, have shown promise in reducing bacterial load and enhancing the protective immune response in TB models, suggesting a synergistic effect when combined with conventional antibiotics. This approach could potentially shorten treatment durations and improve outcomes for TB patients. In summary, AMPs represent a valuable addition to the anti-TB arsenal, offering mechanisms to combat drug-resistant TB strains and improve patient outcomes through direct antimicrobial activity and immune modulation. Their development and delivery for TB treatment continue to be an active area of research, with the goal of integrating them into existing therapeutic strategies.How to prime dendritic cells with tumoral antigen peptides methodsfor antitumoral responses?
5 answers
To prime dendritic cells (DCs) with tumoral antigen peptides for antitumoral responses, various methods have been explored. One approach involves using original DNA constructs encoding a wide range of tumor-associated antigen (TAA) epitopes to transfect ex-vivo-generated DCs of cancer patients, leading to increased cytotoxicity against autologous tumor cells. Another strategy includes utilizing different cancer-related molecules like peptides, recombinant proteins, apoptotic leukemic cells, or whole tumor cells to load DCs, aiming to induce specific immune responses against target cells. Additionally, recent research has shown promising results using allogeneic plasmacytoid dendritic cells (PDCs) as an antigen presentation platform to prime and expand antitumor-specific CD8+ T cells, potentially enhancing the efficacy of therapeutic cancer vaccines. These methods highlight the importance of DCs in orchestrating immune responses against tumors.How much staff does a vaccination point have?
5 answers
A vaccination point typically requires a specific number of staff members based on various factors such as workload, population served, and optimal staffing models. Research indicates that the mean number of staff attending immunization work at vaccination clinics in Zhejiang Province was five per day, with a standard of 0.9 persons serving for 10,000 residents. In mass vaccination centers, an optimized model involved a staff of 180 persons working daily, with a mean rate of 2951 doses injected per day, and at peak, 10,095 injections given in one day. Additionally, a study on nursing homes found that increasing staff vaccination rates was associated with improved outcomes before the Omicron wave, highlighting the importance of staff vaccination in reducing COVID-19 cases and deaths among residents and staff.